NCT06477419 - A Study of Sacituzumab Govitecan in People With Mesothelioma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 21, 2024

Primary Completion Date

June 21, 2029

Study Completion Date

June 21, 2029

Conditions

MesotheliomaMesotheliomas PleuralMesothelioma; Pleura

Interventions

DRUG

Sacituzumab govitecan-hziy

After enrollment, participants will receive SG until disease progression or intolerable toxicity.

Trial Locations (7)

RECRUITING

Memorial Sloan - Kettering Cancer Center, New York

RECRUITING

Memorial Sloan Kettering Westchester, Harrison

RECRUITING

Memorial Sloan Kettering Nassau, Uniondale

RECRUITING

Memorial Sloan Kettering Cancer Center @ Commack, Commack

RECRUITING

Memorial Sloan Kettering Basking Ridge, Basking Ridge

RECRUITING

Memorial Sloan Kettering Monmouth, Middletown

RECRUITING

Memorial Sloan Kettering Bergen, Montvale